Despite operator experience and improved catheter technology, acute vessel closure is inherently associated with percutaneous transluminal coronary angioplasty (PTCA) of complex lesions, This case study descrlbes a patient who developed an occlusive dissection post PTCA at the bifurcation of the lef
Development of a new insertion technique and a new device for the placement of bifurcated airway stents
β Scribed by L. Freitag; E. Tekolf; D. Greschuchna
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 215 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0930-2794
No coin nor oath required. For personal study only.
β¦ Synopsis
We developed a new insertion technique and designed a forceps device for the placement of bifurcated airway stents; 131 of 142 endoscopically placed tracheobronchial Y-stents were inserted with a forceps and a laryngoscope. For the last 52 stent implantations we used the new stent forceps. It was determined to be a simple and safe method without major complications. In 11 cases alternative techniques had to be used. Technique and device are described in detail.
π SIMILAR VOLUMES
## Abstract This report describes a technique for correct positioning of a stent proximal to a bifurcation lesion treated with Vβstents. A second wire passed through the first cell of a stent, the opposite end of the anchor wire technique as first described by Szabo et al, facilitated precise stent
forehead for a maximum of 45 min in five subjects. 6 After application the R3 decreased, whereas R1 and R2 remained unchanged.
## Abstract We report the first clinical experience in eight patients with a new stent and delivery system specifically designed for the treatment of bifurcational lesions. The device (AST SLKβView system) consists of a premounted stent and a delivery system. The stent has a side aperture, which or
## Abstract ## Background: The stenting of aortoβostial lesions in the native coronary circulation, renal arteries, and saphenous vein grafts is technically challenging. ## Methods: We report the first in the world use of the Ostial Proβ’, a novel nitinolβbased device, utilized in conjunction wit